Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q3 FY26 Earnings Presentation
21 slides from Aarti Industries's earnings presentation, Feb 2, 2026
Slide 1: Cover letter to stock exchanges on Investor Presentation
February 2, 2026 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai – 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. BSE CODE : 524
Slide 2: Q3 FY26 Performance Update
A Legacy of Q3 FY26 Excellence Performance Update A Future of 2nd Feb, 2026 Possibilities
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Index
Company overview Index Q3 FY26 Highlights Future Outlook and Roadmap
Slide 5: Index
Company overview Index Q3 FY26 Highlights Future Outlook and Roadmap
Slide 6: Aarti Industries at a Glance
Aarti Industries at a Glance Established by first generation technocrats in 1984 Benzene based Feedstock Assurance and Downstream Products Supply Integrated operations and high-cost optimization Toluene based Technology Sharing Key value chains include Nitro Chloro Benzenes, Di- Downstream Products
Slide 7: Our Ethos
Our Ethos AIL VALUES PURPOSE Right Chemistry for a Brighter Tomorrow VISION To emerge as a Global Partner of Choice for leading consumers of speciality chemicals and intermediates MISSION Delighted Stakeholders CARE INTEGRITY EXCELLENCE 6
Slide 8: Index
Company overview Index Q3 FY26 Highlights Future Outlook and Roadmap
Slide 9: Business Highlights – Q3 FY26
Business Highlights – Q3 FY26 Achieved CSA score of 78 in the S&P Increased volumes for MMA driven by Resumption of US volumes for MMA and Global Corporate Sustainability expanded capacity and higher blending PDCB, with partial impact of US tariff Assessment 2025; placing AIL among volumes on accoun
Slide 10: Q3 & 9M FY26 Highlights (Consolidated)
Q3 & 9M FY26 Highlights (Consolidated) YoY: 22%▲ QoQ: 11%▲ YoY: 37%▲ QoQ: 11%▲ YoY: 189%▲ QoQ: 25%▲ Revenue increased due to: Higher volumes across various products such as MMA, NT, DCB, etc. MMA and PDCB US exports resumed in Q3 Business Volumes Energy Non-Energy YoY: 78%▲ YoY: 11%▲ Q3 Y25 Q2FY26 Q
Slide 11: Capacities and utilization trend for few major products
Capacities and utilization trend for few major products Capacity FY25 Q3 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Y-o-Y Q3 FY26 Product Groups Q-o-Q (in KTPA) (kT) (kT) (kT) (kT) (kT) Q3 Utilization% NCB 108 85.3 22.9 21.7 21.5 24.6 14% 7% 91% DCB 120 88.6 20.8 19.3 22.0 25.9 18% 24% 86% Hydrogenation 60 44.4 1
Slide 12: Revenue by End Use
Revenue by End Use ₹ Cr 8046 2039 2250 2492 6596 Agrochemicals application showing steady Agrochemicals & 12% volume recovery; margins remained under 18% 16% 19% 17% Fertilizers pressure 11% 12% 13% 11% 12% Dyes, Pigment & Printing Inks and Pharma Dyes, Pigments and applications remains stable; volu
Slide 13: Application wise market updates & business highlights (1/2)
Application wise market updates & business highlights (1/2) End Use Agrochemical & Fertilizers Energy & Additives Chloro Anilines, Di Chloro Phenols, Ethylated & Key Products MMA, CaCl2 Fluorinated products Revenue Share 12% 51% Domestic / Exports Domestic 68% Export 32% Domestic 15% Export 85% • Ma
Slide 14: Application wise market updates & business highlights (2/2)
Application wise market updates & business highlights (2/2) Dyes, Pigments & Printing End Use Pharmaceuticals Polymer and additives Inks PNCB, MDCB & Fluorinated Key Products NCBs, DCBH, PNT PDCB, MPDA, ONA compounds Revenue Share 11% 9% 14% Domestic/Exports Domestic 61% Export 39% Domestic 81% Expo
Slide 15: Joint Ventures
Joint Ventures DCA downstream JV with Superform Project progressing well as planned. About 66% of the targeted amount has been invested. Tailwinds in one of the end applications being witnessed; may support quicker capacity utilization Expected commissioning in Q1FY27 Chemical Recycling of plastics
Slide 16: Index
Company overview Index Q3 FY26 Highlights Future Outlook and Roadmap
Slide 17: Key EBITDA Growth Drivers in near term (FY26 - FY28)
Key EBITDA Growth Drivers in near term (FY26 - FY28) Cost Optimisation Volume and margin ramp-up CAPEX-led growth ₹ 150-200 crore ₹ 350-550 crore ₹ 300-450 crore ✔ Switching to Back Pressure Turbine to Acid, DCB & NCB value chain ✔ Pilot commissioned to fuel New improve Cogen ramp-up Product Develop
Slide 18: Growth Outlook – consistent with previous update
Growth Outlook – consistent with previous update EBITDA, ₹ Cr 1800 - 2200 Consistent volume growth over 3 yrs driven by increased capacities Operating leverages and cost optimisation initiatives to drive EBITDA growth beyond volume growth Capex for FY26 estimated to be around ₹ 1100 Cr Target EBITDA
Slide 19: Long term growth focus areas
Long term growth focus areas MPP and Zone 4 Commercialization • R&D and MPP will support quick development, qualification and commercialization of new advanced chemistries • Chlorotoluene commissioning and ramp up will open up new opportunities in Agro and Pharma business segments New Growth Avenues
Slide 20: Certifications
wr Patz w * Certifications G Responsible Care® sar ear TS BRENT ecovadis Sustainability Rating APR 2025 WS SUSTAINABILITY — rN = TOGETHER Iso way’ ISO 45001:2018 ISO 14001 aE] AARTI INDUSTRIES Climate uCDP AList 2024
Slide 21: Thank You
investorrelations@aarti-industries.com Thank You